Table 3. Secondary outcomes of neonates at intervention sites using QUiPP app versus control sites using conventional management.
| Secondary outcome measure | Neonates at intervention sites n/total (%) |
Neonates at control sites n/total (%) |
All neonates n/total (%) |
|---|---|---|---|
| Delivery within 7 days of presentation | 23/725 (3.2) | 40/1,069 (3.7) | 63/1,794 (3.5) |
| Delivery within 14 days | 43/725 (5.9) | 70/1,069 (6.5) | 113/1,794 (6.3) |
| Delivery within 28 days | 117/725 (16.1) | 167/1,069 (15.6) | 284/1,794 (15.8) |
| Preterm delivery <30 weeks | 9/725 (1.2) | 17/1,069 (1.6) | 26/1,794 (1.4) |
| Preterm delivery <34 weeks | 44/725 (6.1) | 53/1,069 (5.0) | 97/1,794 (5.4) |
| Preterm delivery <37 weeks | 127/725 (17.5) | 184/1,069 (17.2) | 311/1,794 (17.3) |
| Unnecessary ACSs | 63/725 (8.7) | 110/1,069 (10.3) | 173/1,794 (9.6) |
| Proportion of women <36/40 given necessary ACSs | 24/87 (27.6) | 24/117 (20.5) | |
| Unnecessary magnesium sulphate | 11/725 (1.5) | 9/1,069 (0.8) | 20/1,794 (1.1) |
| Proportion of women <30/40 given necessary magnesium sulphate | 3/9 (33.3) | 7/17 (41.2) | |
| Tocolysis at any visit | 17/718 (2.4) | 29/1,064 (2.7) | 46/1,782 (2.6) |
| Low birth weight (<2,500 g) | 118/723 (16.3) | 135/1,048 (12.9) | 253/1,771 (14.3) |
| Neonatal death | 2/725 (0.3) | 3/1,069 (0.3) | 5/1,794 (0.3) |
| Oxygen at 28 days | 7/725 (1.0) | 6/1,069 (0.6) | 13/1,794 (0.7) |
ACS, antenatal corticosteroid; QUIPP, QUantitative Innovation in Predicting Preterm birth.